Dmitriy N. Atochin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| JNK Mitogen-Activated Protein Kinases | 7 | 2020 | 452 | 3.210 |
Why?
|
| Oximes | 7 | 2020 | 311 | 2.830 |
Why?
|
| Reperfusion Injury | 10 | 2020 | 1027 | 2.790 |
Why?
|
| Quinoxalines | 6 | 2020 | 289 | 2.610 |
Why?
|
| Brain Ischemia | 17 | 2023 | 3264 | 2.170 |
Why?
|
| Nitric Oxide Synthase Type III | 18 | 2022 | 689 | 2.100 |
Why?
|
| Neuroprotective Agents | 4 | 2020 | 941 | 1.590 |
Why?
|
| Nitric Oxide | 16 | 2022 | 2132 | 0.980 |
Why?
|
| Cerebrovascular Circulation | 17 | 2022 | 2732 | 0.920 |
Why?
|
| Infarction, Middle Cerebral Artery | 7 | 2021 | 476 | 0.910 |
Why?
|
| Neurogenic Inflammation | 1 | 2020 | 33 | 0.740 |
Why?
|
| Cerebral Infarction | 5 | 2019 | 1011 | 0.740 |
Why?
|
| Hyperbaric Oxygenation | 7 | 2011 | 163 | 0.690 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2019 | 30 | 0.680 |
Why?
|
| Nitric Oxide Donors | 3 | 2016 | 121 | 0.580 |
Why?
|
| Rats, Wistar | 8 | 2020 | 1892 | 0.580 |
Why?
|
| Phenylethyl Alcohol | 1 | 2016 | 13 | 0.570 |
Why?
|
| Ligation | 1 | 2017 | 452 | 0.560 |
Why?
|
| Nitric Oxide Synthase Type I | 7 | 2019 | 170 | 0.560 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 5532 | 0.530 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 688 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 1503 | 0.490 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 18027 | 0.480 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1781 | 0.460 |
Why?
|
| Stroke | 8 | 2021 | 9975 | 0.430 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2008 | 534 | 0.430 |
Why?
|
| Nitric Oxide Synthase | 4 | 2003 | 915 | 0.420 |
Why?
|
| Mice, Knockout | 22 | 2022 | 14563 | 0.400 |
Why?
|
| Hippocampus | 3 | 2020 | 3672 | 0.400 |
Why?
|
| Animals | 59 | 2022 | 168660 | 0.380 |
Why?
|
| Hyperoxia | 3 | 2014 | 262 | 0.370 |
Why?
|
| Guanylate Cyclase | 1 | 2010 | 201 | 0.350 |
Why?
|
| Reperfusion | 3 | 2021 | 283 | 0.320 |
Why?
|
| Mice | 40 | 2022 | 81154 | 0.310 |
Why?
|
| Endothelium | 1 | 2010 | 777 | 0.300 |
Why?
|
| Brain Infarction | 3 | 2016 | 299 | 0.300 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2008 | 1263 | 0.290 |
Why?
|
| Oxygen | 11 | 2022 | 4189 | 0.290 |
Why?
|
| Laser-Doppler Flowmetry | 4 | 2017 | 242 | 0.280 |
Why?
|
| Hydrogen Sulfide | 2 | 2021 | 137 | 0.280 |
Why?
|
| Signal Transduction | 7 | 2022 | 23398 | 0.240 |
Why?
|
| Endothelium, Vascular | 5 | 2016 | 4459 | 0.240 |
Why?
|
| Rats | 12 | 2021 | 24250 | 0.240 |
Why?
|
| Nitrogen | 2 | 1995 | 344 | 0.240 |
Why?
|
| Fibrinolysis | 1 | 2004 | 322 | 0.220 |
Why?
|
| Blood-Brain Barrier | 4 | 2016 | 1018 | 0.220 |
Why?
|
| Rats, Inbred SHR | 3 | 2020 | 195 | 0.220 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 202 | 0.210 |
Why?
|
| Ischemic Preconditioning | 1 | 2003 | 92 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 20 | 2021 | 21824 | 0.210 |
Why?
|
| Hypertension | 3 | 2020 | 8480 | 0.210 |
Why?
|
| Water | 2 | 2023 | 1394 | 0.210 |
Why?
|
| Quinone Reductases | 1 | 2021 | 18 | 0.200 |
Why?
|
| Receptors, IgG | 2 | 2016 | 581 | 0.190 |
Why?
|
| Oxygen Consumption | 4 | 2022 | 1869 | 0.190 |
Why?
|
| Phenylacetates | 1 | 2020 | 114 | 0.180 |
Why?
|
| Rats, Inbred WKY | 1 | 2020 | 158 | 0.180 |
Why?
|
| Ischemic Attack, Transient | 2 | 2007 | 934 | 0.180 |
Why?
|
| Blood Viscosity | 1 | 2020 | 124 | 0.180 |
Why?
|
| Helium | 3 | 1995 | 123 | 0.180 |
Why?
|
| Hypothalamus | 3 | 2011 | 1061 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 480 | 0.180 |
Why?
|
| Insulin Resistance | 4 | 2016 | 3863 | 0.170 |
Why?
|
| Delta Rhythm | 1 | 2019 | 78 | 0.170 |
Why?
|
| Atmospheric Pressure | 3 | 1995 | 47 | 0.170 |
Why?
|
| Tyrosine | 1 | 2003 | 1462 | 0.170 |
Why?
|
| Sodium Nitrite | 1 | 2018 | 14 | 0.170 |
Why?
|
| Neurons | 7 | 2019 | 9336 | 0.170 |
Why?
|
| Hematocrit | 1 | 2020 | 636 | 0.160 |
Why?
|
| Catecholamines | 2 | 2011 | 387 | 0.160 |
Why?
|
| Serine | 3 | 2013 | 825 | 0.160 |
Why?
|
| Lipid Peroxidation | 1 | 2019 | 270 | 0.160 |
Why?
|
| Neutrophils | 2 | 2001 | 3718 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 1789 | 0.150 |
Why?
|
| Somatostatin | 1 | 2019 | 459 | 0.150 |
Why?
|
| Ginsenosides | 1 | 2017 | 11 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2020 | 1374 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2017 | 11 | 0.150 |
Why?
|
| Anthracenes | 1 | 2017 | 86 | 0.150 |
Why?
|
| Regional Blood Flow | 4 | 2010 | 1525 | 0.150 |
Why?
|
| Brain | 11 | 2022 | 26345 | 0.150 |
Why?
|
| Microcirculation | 1 | 2022 | 1287 | 0.150 |
Why?
|
| Acetonitriles | 1 | 2017 | 53 | 0.150 |
Why?
|
| Permeability | 2 | 2016 | 738 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15142 | 0.140 |
Why?
|
| Thrombomodulin | 1 | 2016 | 102 | 0.140 |
Why?
|
| Pentoxifylline | 1 | 2016 | 55 | 0.140 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.140 |
Why?
|
| Benzothiazoles | 1 | 2017 | 247 | 0.140 |
Why?
|
| Male | 33 | 2022 | 349776 | 0.130 |
Why?
|
| Mice, Transgenic | 7 | 2019 | 9731 | 0.130 |
Why?
|
| Phosphorylation | 8 | 2022 | 8436 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 112 | 0.130 |
Why?
|
| Brain Injuries | 2 | 2021 | 2029 | 0.130 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 354 | 0.130 |
Why?
|
| Endotoxemia | 1 | 2016 | 207 | 0.130 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1995 | 88 | 0.130 |
Why?
|
| Nanomedicine | 1 | 2017 | 302 | 0.120 |
Why?
|
| Ischemic Postconditioning | 1 | 2014 | 25 | 0.120 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 1084 | 0.120 |
Why?
|
| Erythrocytes | 2 | 2016 | 2455 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2017 | 471 | 0.110 |
Why?
|
| Carbon Dioxide | 2 | 1995 | 1150 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1524 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2013 | 595 | 0.110 |
Why?
|
| Cell Count | 1 | 2017 | 1855 | 0.110 |
Why?
|
| Motor Skills | 1 | 2016 | 522 | 0.110 |
Why?
|
| Heart | 2 | 2020 | 4460 | 0.110 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.110 |
Why?
|
| Myocardial Reperfusion | 1 | 2014 | 351 | 0.110 |
Why?
|
| Hyperlipidemias | 2 | 2018 | 789 | 0.110 |
Why?
|
| Environment, Controlled | 1 | 1992 | 46 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2022 | 2899 | 0.100 |
Why?
|
| Mitochondria, Heart | 2 | 2011 | 247 | 0.100 |
Why?
|
| Time Factors | 11 | 2020 | 40038 | 0.100 |
Why?
|
| Quinazolines | 1 | 2018 | 1356 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 500 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 974 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1060 | 0.100 |
Why?
|
| Blood Volume | 1 | 2013 | 565 | 0.100 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 5692 | 0.100 |
Why?
|
| Water Deprivation | 1 | 2010 | 21 | 0.100 |
Why?
|
| Motor Activity | 2 | 2016 | 2714 | 0.090 |
Why?
|
| Paraplegia | 1 | 2011 | 169 | 0.090 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2014 | 476 | 0.090 |
Why?
|
| Caspase 9 | 1 | 2010 | 188 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2011 | 408 | 0.090 |
Why?
|
| Homeostasis | 2 | 2018 | 3337 | 0.090 |
Why?
|
| Spinal Cord Ischemia | 1 | 2011 | 94 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2016 | 1880 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10940 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2020 | 4197 | 0.090 |
Why?
|
| Memory | 1 | 2019 | 2173 | 0.090 |
Why?
|
| Insulin | 2 | 2016 | 6584 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2018 | 5445 | 0.090 |
Why?
|
| Vasoconstriction | 2 | 2003 | 597 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4925 | 0.080 |
Why?
|
| Visual Cortex | 1 | 2017 | 1136 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.080 |
Why?
|
| Glucose | 4 | 2016 | 4398 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4477 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2011 | 758 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1157 | 0.080 |
Why?
|
| Antioxidants | 1 | 2016 | 1658 | 0.080 |
Why?
|
| Peptides | 1 | 2020 | 4406 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 791 | 0.080 |
Why?
|
| Partial Pressure | 4 | 1998 | 254 | 0.080 |
Why?
|
| Intracranial Thrombosis | 1 | 2008 | 113 | 0.080 |
Why?
|
| Body Water | 1 | 2008 | 343 | 0.070 |
Why?
|
| Atmosphere Exposure Chambers | 4 | 1995 | 50 | 0.070 |
Why?
|
| Globins | 1 | 2008 | 416 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 896 | 0.070 |
Why?
|
| Microdialysis | 2 | 2003 | 158 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4463 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1213 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2217 | 0.070 |
Why?
|
| Motor Neurons | 1 | 2011 | 841 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1360 | 0.070 |
Why?
|
| Vasopressins | 1 | 2007 | 370 | 0.070 |
Why?
|
| Dehydration | 1 | 2007 | 232 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2007 | 637 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1793 | 0.070 |
Why?
|
| Macrophages | 1 | 2020 | 5651 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 836 | 0.060 |
Why?
|
| Alanine | 1 | 2007 | 571 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1161 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 8300 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 494 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2016 | 3778 | 0.060 |
Why?
|
| Injections, Intra-Arterial | 1 | 2004 | 193 | 0.060 |
Why?
|
| Humans | 17 | 2023 | 743811 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2883 | 0.060 |
Why?
|
| Tail | 1 | 2004 | 97 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 1225 | 0.060 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 565 | 0.060 |
Why?
|
| Brain Damage, Chronic | 1 | 2004 | 263 | 0.060 |
Why?
|
| Aging | 2 | 2022 | 8655 | 0.060 |
Why?
|
| Nitrites | 1 | 2003 | 160 | 0.060 |
Why?
|
| Mice, Congenic | 1 | 2003 | 99 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.060 |
Why?
|
| Guinea Pigs | 3 | 1995 | 1386 | 0.060 |
Why?
|
| Adiposity | 1 | 2013 | 1806 | 0.050 |
Why?
|
| Telencephalon | 1 | 2003 | 141 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11478 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 1631 | 0.050 |
Why?
|
| Genotype | 2 | 2010 | 12944 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10179 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 35409 | 0.050 |
Why?
|
| Leukocytes | 1 | 2010 | 2044 | 0.050 |
Why?
|
| Nitrates | 1 | 2003 | 265 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1422 | 0.050 |
Why?
|
| Fibrin | 1 | 2004 | 505 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2004 | 445 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 2029 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11360 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2011 | 3082 | 0.050 |
Why?
|
| Electrodes, Implanted | 3 | 1995 | 825 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2004 | 1035 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 12066 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 2074 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 642 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 298 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2327 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 2504 | 0.040 |
Why?
|
| Particle Size | 1 | 2004 | 1639 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 115 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2001 | 264 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2008 | 4221 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 2944 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2010 | 2509 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 6865 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2022 | 19232 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2162 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15518 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 3660 | 0.040 |
Why?
|
| Edema | 2 | 2018 | 789 | 0.040 |
Why?
|
| Eye | 1 | 2003 | 727 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2657 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2013 | 8551 | 0.040 |
Why?
|
| Lasers | 1 | 2022 | 949 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2014 | 1436 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2003 | 832 | 0.040 |
Why?
|
| Glycolysis | 1 | 2022 | 830 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2020 | 906 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1887 | 0.040 |
Why?
|
| Blood | 1 | 2020 | 596 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2019 | 63042 | 0.040 |
Why?
|
| NAD | 1 | 2021 | 590 | 0.040 |
Why?
|
| Membrane Fusion Proteins | 1 | 2016 | 3 | 0.040 |
Why?
|
| Myocardium | 1 | 2010 | 4775 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 2183 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2001 | 793 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3482 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 2003 | 1219 | 0.040 |
Why?
|
| Peroxidase | 1 | 2000 | 611 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9272 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 2020 | 541 | 0.030 |
Why?
|
| Decompression | 1 | 1995 | 43 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2022 | 4437 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3320 | 0.030 |
Why?
|
| Blood-Air Barrier | 1 | 1995 | 25 | 0.030 |
Why?
|
| Cell Death | 2 | 2012 | 1705 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10477 | 0.030 |
Why?
|
| Neutropenia | 1 | 2000 | 895 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1998 | 554 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2007 | 471 | 0.030 |
Why?
|
| Air Pressure | 1 | 1994 | 75 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1894 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21675 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 11729 | 0.030 |
Why?
|
| Models, Animal | 1 | 2000 | 2172 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 690 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3128 | 0.030 |
Why?
|
| Neon | 1 | 1992 | 1 | 0.030 |
Why?
|
| High Pressure Neurological Syndrome | 1 | 1992 | 3 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2013 | 210 | 0.030 |
Why?
|
| Superoxides | 1 | 2013 | 387 | 0.030 |
Why?
|
| Protective Agents | 1 | 2013 | 156 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2217 | 0.030 |
Why?
|
| RNA Interference | 1 | 2021 | 2890 | 0.030 |
Why?
|
| Fasting | 1 | 2018 | 1590 | 0.030 |
Why?
|
| Cytokines | 2 | 2020 | 7324 | 0.030 |
Why?
|
| Enzyme Inhibitors | 3 | 2011 | 3794 | 0.030 |
Why?
|
| Uncoupling Agents | 1 | 2011 | 45 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Memantine | 1 | 2012 | 100 | 0.030 |
Why?
|
| Haplotypes | 1 | 2018 | 2779 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 418 | 0.020 |
Why?
|
| Biological Transport | 1 | 2016 | 2119 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 707 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6356 | 0.020 |
Why?
|
| Mutation | 3 | 2013 | 29777 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 1995 | 1615 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3912 | 0.020 |
Why?
|
| Seizures | 1 | 2003 | 2850 | 0.020 |
Why?
|
| Monocytes | 1 | 2020 | 2593 | 0.020 |
Why?
|
| Ischemia | 2 | 2012 | 1907 | 0.020 |
Why?
|
| Cattle | 1 | 2016 | 3917 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2012 | 626 | 0.020 |
Why?
|
| Electroencephalography | 3 | 2019 | 6061 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 449 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 936 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 590 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2014 | 5986 | 0.020 |
Why?
|
| Vasculitis | 1 | 2013 | 519 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1794 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5524 | 0.020 |
Why?
|
| Rabbits | 1 | 1995 | 4894 | 0.020 |
Why?
|
| Female | 4 | 2021 | 380020 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2008 | 105 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 544 | 0.020 |
Why?
|
| alpha-Methyltyrosine | 1 | 2007 | 6 | 0.020 |
Why?
|
| Aorta | 1 | 2016 | 2062 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3513 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 730 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1572 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1995 | 1738 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
| Acute Disease | 2 | 2008 | 7150 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2008 | 13028 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 2008 | 0.020 |
Why?
|
| Cell Movement | 1 | 2000 | 5216 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2008 | 209 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 135 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 10896 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2013 | 6188 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Phenotype | 2 | 2020 | 16361 | 0.020 |
Why?
|
| Drug Design | 1 | 2012 | 1075 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 255 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 644 | 0.020 |
Why?
|
| Time | 1 | 2008 | 542 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 528 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1898 | 0.020 |
Why?
|
| Kinetics | 1 | 2014 | 6476 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Neuroglia | 1 | 2011 | 928 | 0.020 |
Why?
|
| Fibrinolysin | 1 | 2005 | 131 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 1638 | 0.020 |
Why?
|
| Hydrogen | 1 | 2005 | 164 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2500 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1862 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1986 | 0.020 |
Why?
|
| Models, Biological | 2 | 2013 | 9582 | 0.020 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 41 | 0.010 |
Why?
|
| Sleep | 1 | 2019 | 4619 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1952 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2011 | 2016 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2003 | 145 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1800 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6620 | 0.010 |
Why?
|
| Weight Gain | 1 | 2013 | 2294 | 0.010 |
Why?
|
| Hyperemia | 1 | 2003 | 225 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1504 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5881 | 0.010 |
Why?
|
| Perfusion | 1 | 2005 | 1359 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5301 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21733 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 1728 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4749 | 0.010 |
Why?
|
| Pressure | 1 | 2000 | 1205 | 0.010 |
Why?
|
| Inflammation | 1 | 2016 | 10629 | 0.010 |
Why?
|
| Cats | 1 | 1998 | 986 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 1998 | 292 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16674 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 9718 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 213889 | 0.010 |
Why?
|
| Prognosis | 1 | 1995 | 29052 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7793 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77410 | 0.010 |
Why?
|
| Wakefulness | 1 | 2000 | 1243 | 0.010 |
Why?
|
| Macaca | 1 | 1994 | 439 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1994 | 448 | 0.010 |
Why?
|
| Anesthesia | 1 | 2000 | 1562 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 9858 | 0.010 |
Why?
|
| Temperature | 1 | 1992 | 2202 | 0.000 |
Why?
|
| Middle Aged | 1 | 2018 | 213241 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 14714 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1992 | 6441 | 0.000 |
Why?
|